Table 5.

Case-fatality by COVID-19 in cancer patients in selected studies.

COVID-19/Cancer	N patients (% death)
Liang et al. [15]	18 (50%)
Garassino et al. [8]	200 (33,3%)
Melo et al. [11]	181 (33,1%)
Mehta et al. [9]	218 (28%)
Luo et al. [16]	69 (24%)
Barlesi et al. [13]	137 (15%)
Fernandes et al. (2021)	411 (12,4%)
Dai et al. [7]	154 (11,4%)
Robilotti et al. [12]	423 (9%)

The values in bold are significant.